Law Firm Urges Hims & Hers Stockholders to Contact Regarding Class Action Lawsuit

Robbins LLP has urged stockholders of Hims & Hers Health, Inc. to contact the firm for information concerning a class action lawsuit filed against the company. The lawsuit, initiated on behalf of individuals and entities who purchased Hims & Hers securities between August 4, 2025, and July 29, 2026, alleges that the health and wellness platform shared customers' protected health information with advertising platforms and engaged in other deceptive practices.

The complaint cites a July 2026 announcement by the Federal Trade Commission (FTC), which filed a lawsuit accusing the telehealth provider of sharing sensitive health data with third-party advertising platforms, contrary to its privacy promises. The FTC also alleges that Hims & Hers misled users regarding its billing and cancellation policies, charging consumers for prescriptions almost immediately after they submitted intake forms, despite marketing these as consultations to find the right treatment.

Following this news, Hims & Hers stock experienced a decline of approximately 14.7 percent on July 29, 2026. Robbins LLP reminds investors who incurred significant losses during the specified period that they may be eligible to participate in the lawsuit. The deadline to seek appointment as lead plaintiff is November 2, 2026.

The law firm states that participation in the lawsuit is at no cost to investors, as they represent clients on a contingency fee basis. Robbins LLP has a history of representing investors in shareholder rights litigation.